SCHEMBL20845137

SCHEMBL20845137

C1=C\c2cc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)ccc2-c2ccccc2Sc2ccccc2-c2ccccc2/1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 0.37
▸ KMT2A Q03164 5/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ MAPT P10636 3/20 0.37
▸ HPGD P15428 2/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ NTSR1 P30989 1/20 0.34
▸ ADORA2A P29274 3/20 0.34
▸ ADORA1 P30542 3/20 0.34
▸ ADORA3 P0DMS8 2/20 0.34
▸ ADORA2B P29275 2/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ LMNA P02545 4/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ GPR55 Q9Y2T6 1/20 0.33
▸ GLA P06280 1/20 0.33
▸ GPR84 Q9NQS5 2/20 0.32
▸ POLB P06746 2/20 0.32
▸ HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20845141 0.91 MEN1 (0.37) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL20845325 0.90 MEN1 (0.36) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL20845323 0.87 MEN1 (0.34) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL20845322 0.87 MEN1 (0.34) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL20845319 0.85 GP6 (0.33) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL20845239 0.83 MEN1 (0.42) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL20222565 0.83 MEN1 (0.43) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL20222839 0.83 MEN1 (0.43) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL20845138 0.82 MEN1 (0.44) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL20222577 0.82 MEN1 (0.46) MEN1KMT2AALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190092745-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2019-03-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190092745-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME SCO2, AOX1, ORC3 MEN1 3151/4885KMT2A 880/4885ALDH1A1 981/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback